Evaluation of Visual Acuity With a Reusable Toric Multifocal Contact Lens

NCT05000164 | Completed Results FDA Device

• 1 other identifier: CR-6383
• Study Type: interventional
• Target: 75
• Locations: 1 country
• Sites: 9

Brief Summary

The study is a bilateral, single-masked, single-arm, 4-visit dispensing study evaluating the visual performance of the study lenses.

Conditions

Visual Acuity

Outcome Measures

Primary Outcomes (1)

• Binocular High Luminance High Contrast logMAR Visual Acuity

  Binocular visual acuity was measured on a logMAR (Logarithm of Minimal Angle of Resolution) scale under high luminance high contrast condition. At distance (4 meters), VA is assessed using ETDRS (Early Treatment Diabetic Retinopathy Study) charts; while near (40 cm) and intermediate (64 cm) assessments were made using reduced Guillon-Poling charts. Letter-by-letter results calculated the visual performance score for each chart read. LogMAR scores closer to zero, or below zero, indicate a better visual acuity. A logMAR visual performance score of 0.0 is equivalent to Snellen visual acuity of 20/20.

  4-Week Follow-up

Study Arms (1)

Market Product

EXPERIMENTAL

Eligible subjects will be dispensed the study lenses in a bilateral fashion and will be in the treatment for approximately 5 weeks.

Device: Bausch + Lomb Ultra® Multifocal for Astigmatism

Interventions

Bausch + Lomb Ultra® Multifocal for Astigmatism DEVICE

Study Lens

Market Product

Eligibility Criteria

• Age: 40 Years - 70 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Potential subjects must satisfy all of the following criteria to be enrolled in the study:
• Read, understand, and sign the STATEMENT OF INFORMED CONSENT and receive a fully executed copy of the form.
• Appear able and willing to adhere to the instructions set forth in this clinical protocol.
• Be at least 40 and not more than 70 years of age at the time of screening.
• Own a wearable pair of spectacles if required for their distance vision.
• Be an adapted soft contact lens wearer in both eyes (i.e. has worn lenses a minimum of 2 days per week for at least 8 hours per wear day, for the past month).
• Be an existing wearer of a presbyopic contact lens correction (e.g., reading spectacles over contact lenses, multifocal or monovision contact lenses, etc.) or respond positively to at least one symptom on the "Presbyopic Symptoms Questionnaire".
• Have distance spherical component of refraction in the range of either -1.25 D to -3.75 D or +1.25 to +3.75 D in each eye.
• Have refractive cylinder in the range of -0.75 D to -1.75 D in each eye, with their cylinder axis 90°±25°.
• Have near ADD power requirement in the range of +0.75 D to +2.50 D in each eye.
• Have best corrected distance visual acuity of 20/20-3 or better in each eye.

You may not qualify if:

• The subject must not:
• Be currently pregnant or lactating.
• Have any active or ongoing ocular or systemic allergies that may interfere with contact lens wear.
• Have any active or ongoing systemic disease, autoimmune disease, or use of medication, which may interfere with contact lens wear. This may include, but not be limited to, diabetes, hyperthyroidism, Sjögren's syndrome, xerophthalmia, acne rosacea, Stevens- Johnson syndrome, and immunosuppressive diseases or any infectious diseases (e.g. hepatitis, tuberculosis).
• Use systemic medications that may interfere with contact lens wear or cause blurred vision. See section 9.1 for additional details regarding excluded systemic medications.
• Currently use ocular medication with the exception of rewetting drops.
• Have any known hypersensitivity or allergic reaction to single use preservative free rewetting drops, sodium fluorescein, or Biotrue® multipurpose solution.
• Have any previous, or planned, ocular or intraocular surgery (e.g. radial keratotomy, PRK, LASIK, lid procedures, cataract surgery, retinal surgery, etc.).
• Have a history of amblyopia or strabismus.
• Have a history of herpetic keratitis.
• Have a history of irregular cornea.
• Have a history of pathological dry eye.
• Have participated in any contact lens or lens care product clinical trial within 14 days prior to study enrollment.
• Be an employee or immediate family member of an employee of clinical site (e.g., Investigator, Coordinator, Technician).
• Have clinically significant (Grade 2 or greater) corneal edema, corneal vascularization, corneal staining, tarsal abnormalities or bulbar injection, or any other corneal or ocular abnormalities which would contraindicate contact lens wear.

Sponsors & Collaborators

• Johnson & Johnson Vision Care, Inc.: lead

Study Sites (9)

Vue Optical Boutique

Jacksonville, Florida, 32205, United States

Location

Stam & Associates Eye Care

Jacksonville, Florida, 32256, United States

Location

VRC-East

Jacksonville, Florida, 32256, United States

Location

Maitland Vision Center

Maitland, Florida, 32751, United States

Location

The Eyecare Studio

Decatur, Georgia, 13850, United States

Location

Ctr For Opht and Vision Rsrch At Eye Associates Of New York

Manhattan, New York, 10222, United States

Location

Sacco Eye Group

Vestal, New York, 13850, United States

Location

Vision Boutique

Houston, Texas, 77005, United States

Location

Botetourt Eyecare LLC

Salem, Virginia, 24153, United States

Location

Results Point of Contact

• Title: Ross Franklin, BAppSc-Optom
• Organization: Johnson & Johnson Vision Care (JJVC)

RFRANKL1@its.jnj.com

1-800-843-2020

Study Officials

• Johnson & Johnson Vision Care, Inc. Clinical Trial

  Johnson & Johnson Vision Care, Inc.

  STUDY DIRECTOR

Publication Agreements

• PI is Sponsor Employee: No
• Restriction Type: GT60
• Restrictive Agreement: Yes

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Masking Details: Subjects will be unaware of the identity of the investigational product to help reduce potential bias
• Purpose: TREATMENT
• Intervention Model: SINGLE GROUP
• Sponsor Type: INDUSTRY
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: August 3, 2021
• First Posted: August 11, 2021
• Study Start: August 2, 2021
• Primary Completion: January 13, 2022
• Study Completion: January 13, 2022
• Last Updated: January 23, 2023
• Results First Posted: January 23, 2023

Record last verified: 2023-01

Data Sharing

• IPD Sharing: Will share

Locations

US (9)